Pharmacovigilance is essential for oncologists to improve patient treatment by enhancing reporting practices. A focus on patient-centric approaches ensures their needs are prioritised. Discussions highlight the importance of pharmacogenetics and genomics in personalising care, which helps reduce adverse effects and improve compliance. This personalised care not only benefits patients but also alleviates economic burdens on communities, showcasing the significant role of technology in reducing patient suffering.